Phoenix Molecular Designs Appoints Leading Oncology Expert Dr. Gerrit Los as Chief Scientific Officer

Written by Guest User

Jul. 17
2017

July 17, 2017 - Leading expert in Oncology, Pharmacology and Translational Medicine, Dr. Gerrit Los has been appointed as our new Chief Scientific Officer. With his expertise and guidance, PhoenixMD is advancing our program to bring our RSK kinase inhibitors to the clinic to treat the most devastating of breast cancers, Triple Negative Breast Cancer. Read the full press release here

Guest User
Previous

Phoenix Molecular Designs team members meet with investors to discuss partnership opportunities at premier Life Science events in the US.
Next

San Diego trade mission to Vancouver announces Phoenix Molecular Designs' expansion into the USA